Advances in the study of CD47‐based bispecific antibody in cancer immunotherapy
Sign Up to like & getrecommendations! Published in 2022 at "Immunology"
DOI: 10.1111/imm.13498
Abstract: Tumour therapy has entered the era of immunotherapy. Monoclonal antibodies (mAb), immune checkpoint inhibitors, chimeric antigen receptor T‐cell (CAR‐T), cytokine‐induced killer (CIK), tumour‐infiltrating lymphocytes (TILs) and other cellular immunotherapies have become the focus of current… read more here.
Keywords: immunotherapy; cd47 based; cd47 sirp; based bispecific ... See more keywords